Home › Xadago (Safinamide) New Drug Application (NDA) Accepted For Filing By The U.S. Food And Drug Administration (FDA)
 

Keywords :   


Xadago (Safinamide) New Drug Application (NDA) Accepted For Filing By The U.S. Food And Drug Administration (FDA)

2015-03-04 02:40:12| drugdiscoveryonline Home Page

Newron Pharmaceuticals S.p.A. (“Newron”), a research and development company focused on novel central nervous system (CNS) and pain therapies, and its commercial and development partner, Zambon S.p.A., an international pharmaceutical company, announced recently that the New Drug Application (NDA) for Xadago (safinamide) has been accepted for filing by the U.S. Food and Drug Administration (FDA)

Tags: food application administration accepted

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
14.05Cow dung's key role in India's energy industry
14.05May hay stocks provide early perspective on 2024 hay supply
13.05Dantex announces new digital director for Pico division
13.05Tonny De Beer Joins First Quality
13.05Join us for the 2024 Global Hog Industry Virtual Conference
13.05New version of Chat-GPT can teach maths and flirt
13.05Eastern North Pacific Tropical Weather Outlook
13.05Melinda French Gates to quit Gates Foundation
More »